Correction: PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3Kα Inhibitors

MLA

Sarah Croessmann, et al. “Correction: PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-Kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3Kα Inhibitors.” Clinical Cancer Research, vol. 25, Feb. 2019, p. 1432. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........7c4fa38ec39b30769a217a138bb1a343&authtype=sso&custid=ns315887.

APA

Sarah Croessmann, Justin M. Balko, Carlos L. Arteaga, Jie He, Jens Meiler, David A. Riddle, Ingrid A. Mayer, Kyung Min Lee, Richard B. Lanman, Rebecca Nagy, Gregory Sliwoski, Lewis C. Cantley, Jonathan H. Sheehan, & Vincent A. Miller. (2019). Correction: PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3Kα Inhibitors. Clinical Cancer Research, 25, 1432.

Chicago

Sarah Croessmann, Justin M. Balko, Carlos L. Arteaga, Jie He, Jens Meiler, David A. Riddle, Ingrid A. Mayer, et al. 2019. “Correction: PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-Kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3Kα Inhibitors.” Clinical Cancer Research 25 (February): 1432. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........7c4fa38ec39b30769a217a138bb1a343&authtype=sso&custid=ns315887.